Invention Grant
US08822477B2 Use of osmolytes obtained from extremophilic bacteria for producing medicine for the external treatment of neurodermatitis 有权
使用从极细菌获得的渗透剂用于制造用于神经性皮炎外部治疗的药物

  • Patent Title: Use of osmolytes obtained from extremophilic bacteria for producing medicine for the external treatment of neurodermatitis
  • Patent Title (中): 使用从极细菌获得的渗透剂用于制造用于神经性皮炎外部治疗的药物
  • Application No.: US10563586
    Application Date: 2004-07-01
  • Publication No.: US08822477B2
    Publication Date: 2014-09-02
  • Inventor: Jean Krutmann
  • Applicant: Jean Krutmann
  • Applicant Address: DE
  • Assignee: Bitop AG
  • Current Assignee: Bitop AG
  • Current Assignee Address: DE
  • Agency: Berliner & Associates
  • Priority: DE10330243 20030703
  • International Application: PCT/EP2004/007134 WO 20040701
  • International Announcement: WO2005/002581 WO 20050113
  • Main IPC: A61K31/505
  • IPC: A61K31/505 A61K9/127
Use of osmolytes obtained from extremophilic bacteria for producing medicine for the external treatment of neurodermatitis
Abstract:
The invention relates to the use of osmolytes, in particular ectoine and hydroxyectoine, as well as their pharmacologically compatible salts and/or derivatives having equivalent effects, for producing dermatological preparations such as tinctures, lotions, O/W emulsions, W/O emulsions, creams, ointments, hydrogels or sprays for the topical prophylaxis, care and/or treatment of neurodermatitis.
Information query
Patent Agency Ranking
0/0